This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Hsi: It's been a ...

A 73-year-old male with a history of relapsed/refractory NK T-cell lymphoma, s/p chemo and immune checkpoint inhibitors therapy. The patient now presents with new onset nephrotic syndrome and acute ...

The funding will help transition the company’s AI lymphoma diagnostic into clinical use, with initial deployments in NHS ...

Manchester University spin-out Spotlight Pathology has raised £1.4m to accelerate commercial roll out of its AI-powered ...

Racial and Ethnic Differences in Advance Care Planning Among Patients With Cancer: Impact of Terminal Illness Acknowledgment, Religiousness, and Treatment Preferences A cohort of 1,314 cases of PTCL ...

It develops from the abnormal multiplication of T cells, or T-lymphocytes, a type of white blood cell essential for immune system function. The specific treatment course and prognosis for T-cell ...

Nationally recognized pediatric oncologist, physician--scientist, and lymphoma survivor Lisa G. Roth, MD, has joined Hassenfeld Children's Hospital at NYU Langone and Perlmutter Cancer Center as ...

Oura’s chief medical officer has reportedly linked the company’s smart ring to the early detection of multiple lymphoma cases, claiming the device flagged unusual physiological patterns that prompted ...

In Asia, PTCL diagnosis and management are hindered by the lack of available domain experts, limitations in infrastructure support and funding, and substantial challenges in accessing novel drugs; ...

A new study from researchers at Uppsala University presents novel findings on why human lymph nodes lose their function with age and the consequences for the effectiveness of our immune system. The ...